Annual CFO:
-$232.32M-$48.15M(-26.14%)Summary
- As of today, VRDN annual cash from operations is -$232.32 million, with the most recent change of -$48.15 million (-26.14%) on December 31, 2024.
- During the last 3 years, VRDN annual cash from operations has fallen by -$177.74 million (-325.64%).
- VRDN annual cash from operations is now -19790.33% below its all-time high of -$1.17 million, reached on December 31, 2013.
Performance
VRDN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$75.37M+$17.28M(+18.65%)Summary
- As of today, VRDN quarterly cash from operations is -$75.37 million, with the most recent change of +$17.28 million (+18.65%) on June 30, 2025.
- Over the past year, VRDN quarterly cash from operations has dropped by -$29.32 million (-63.65%).
- VRDN quarterly cash from operations is now -35826.12% below its all-time high of -$209.80 thousand, reached on December 1, 2012.
Performance
VRDN Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$309.06M-$29.32M(-10.48%)Summary
- As of today, VRDN TTM cash from operations is -$309.06 million, with the most recent change of -$29.32 million (-10.48%) on June 30, 2025.
- Over the past year, VRDN TTM cash from operations has dropped by -$140.80 million (-83.68%).
- VRDN TTM cash from operations is now -147213.63% below its all-time high of -$209.80 thousand, reached on December 1, 2012.
Performance
VRDN TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VRDN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -26.1% | -63.6% | -83.7% |
| 3Y3 Years | -325.6% | -316.8% | -357.6% |
| 5Y5 Years | -544.3% | -1010.2% | -998.0% |
VRDN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -325.6% | at low | -98.3% | +18.6% | -286.1% | at low |
| 5Y | 5-Year | -680.1% | at low | -1379.3% | +18.6% | -998.0% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | +18.6% | >-9999.0% | at low |
VRDN Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$75.37M(+18.7%) | -$309.06M(-10.5%) |
| Mar 2025 | - | -$92.65M(-26.3%) | -$279.75M(-20.4%) |
| Dec 2024 | -$232.32M(-26.1%) | -$73.33M(-8.3%) | -$232.32M(-17.9%) |
| Sep 2024 | - | -$67.71M(-47.0%) | -$196.99M(-17.1%) |
| Jun 2024 | - | -$46.06M(-1.8%) | -$168.26M(-0.5%) |
| Mar 2024 | - | -$45.22M(-19.0%) | -$167.42M(+9.1%) |
| Dec 2023 | -$184.17M(-96.3%) | -$38.00M(+2.5%) | -$184.17M(-26.0%) |
| Sep 2023 | - | -$38.98M(+13.8%) | -$146.17M(-36.4%) |
| Jun 2023 | - | -$45.21M(+27.0%) | -$107.19M(-33.9%) |
| Mar 2023 | - | -$61.97M(-242.7%) | -$80.06M(-18.5%) |
| Dec 2022 | -$93.84M(-71.9%) | - | - |
| Jun 2022 | - | -$18.09M(+14.0%) | -$67.54M(-5.4%) |
| Mar 2022 | - | -$21.04M(-27.3%) | -$64.08M(-17.4%) |
| Dec 2021 | -$54.58M(-83.3%) | -$16.54M(-39.2%) | -$54.58M(-15.0%) |
| Sep 2021 | - | -$11.88M(+18.8%) | -$47.48M(-16.7%) |
| Jun 2021 | - | -$14.63M(-26.8%) | -$40.70M(-23.9%) |
| Mar 2021 | - | -$11.54M(-22.3%) | -$32.86M(-10.3%) |
| Dec 2020 | -$29.78M(+17.4%) | -$9.44M(-85.2%) | -$29.78M(-5.8%) |
| Sep 2020 | - | -$5.09M(+25.0%) | -$28.15M(+12.9%) |
| Jun 2020 | - | -$6.79M(+19.7%) | -$32.32M(+1.2%) |
| Mar 2020 | - | -$8.46M(-8.4%) | -$32.71M(+9.3%) |
| Dec 2019 | -$36.06M | -$7.81M(+15.8%) | -$36.06M(+1.0%) |
| Sep 2019 | - | -$9.27M(-29.2%) | -$36.42M(-7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$7.17M(+39.2%) | -$33.96M(-8.5%) |
| Mar 2019 | - | -$11.81M(-44.5%) | -$31.29M(-16.6%) |
| Dec 2018 | -$26.84M(+4.7%) | -$8.18M(-20.2%) | -$26.84M(-3.6%) |
| Sep 2018 | - | -$6.80M(-51.0%) | -$25.91M(-4.6%) |
| Jun 2018 | - | -$4.51M(+38.8%) | -$24.77M(+9.4%) |
| Mar 2018 | - | -$7.36M(-1.6%) | -$27.34M(+2.9%) |
| Dec 2017 | -$28.17M(-289.5%) | -$7.24M(-27.9%) | -$28.17M(-16.3%) |
| Sep 2017 | - | -$5.66M(+20.0%) | -$24.21M(+6.1%) |
| Jun 2017 | - | -$7.08M(+13.5%) | -$25.79M(-24.5%) |
| Mar 2017 | - | -$8.18M(-149.0%) | -$20.72M(-40.4%) |
| Dec 2016 | -$7.23M(-4.8%) | -$3.29M(+54.6%) | -$14.76M(-15.6%) |
| Sep 2016 | - | -$7.24M(-260.5%) | -$12.77M(-63.0%) |
| Jun 2016 | - | -$2.01M(+9.6%) | -$7.83M(+2.2%) |
| Mar 2016 | - | -$2.22M(-71.1%) | -$8.01M(-16.1%) |
| Dec 2015 | -$6.90M(-211.7%) | -$1.30M(+43.6%) | -$6.90M(-4.6%) |
| Sep 2015 | - | -$2.30M(-5.4%) | -$6.60M(-28.8%) |
| Jun 2015 | - | -$2.19M(-97.1%) | -$5.12M(-74.4%) |
| Mar 2015 | - | -$1.11M(-11.3%) | -$2.94M(-60.7%) |
| Dec 2014 | -$2.21M(-89.5%) | -$996.80K(-20.0%) | -$1.83M(-53.8%) |
| Sep 2014 | - | -$831.00K(-132.4%) | -$1.19M(-232.4%) |
| Dec 2013 | -$1.17M(+81.2%) | -$357.50K(-70.4%) | -$357.50K(-70.4%) |
| Dec 2012 | -$6.22M | - | - |
| Dec 2012 | - | -$209.80K | -$209.80K |
FAQ
- What is Viridian Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Viridian Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Viridian Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of VRDN is -$232.32M
What is the all-time high annual cash from operations for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual cash from operations is -$1.17M
What is Viridian Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, VRDN annual cash from operations has changed by -$48.15M (-26.14%)
What is Viridian Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of VRDN is -$75.37M
What is the all-time high quarterly cash from operations for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly cash from operations is -$209.80K
What is Viridian Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, VRDN quarterly cash from operations has changed by -$29.32M (-63.65%)
What is Viridian Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of VRDN is -$309.06M
What is the all-time high TTM cash from operations for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM cash from operations is -$209.80K
What is Viridian Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, VRDN TTM cash from operations has changed by -$140.80M (-83.68%)